Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Canopy Growth Corp
Bullboard Posts
User Avatar Image
(2)
•••
Post by BatmanMTLon Dec 02, 2016 12:49am
354 Views
Post# 25544694

BUY!$6B MARKET, CGC MEDICAL LEADER+ANSWER TO SUPPLY SHORTAGE

BUY!$6B MARKET, CGC MEDICAL LEADER+ANSWER TO SUPPLY SHORTAGEThe intial rise post US election was foolish. Now we have TANGIBLE news
  • CGC will now be the market leader of the medical market
  • CGC/MT = In CANADA, BRAZIL, GERMANY, and soon AUSTRALIA (Summer 2017)
  • TASK FORCE REPORT IS IN = Canada on track to $6B-$12B REC Market which FAVORS EXISTING SUPPLIERS
  • There will be supply shortage = CGC best poised to address it with 6 licensed facilities >650,000 SQ FEET! 
To sell now makes no sense to me. You buy like Goldman sachs. 



Bullboard Posts
Dealroom for high-potential pre-IPO opportunities